Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023- EU5

Publisher Name :
Date: 01-Nov-2016
No. of pages: 60
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023-EU5" report provides an overview of the disease and global market size of the Celiac Disease for the EU5 countries (France, Germany, Italy, Spain and UK)). It also includes historical and forecasted epidemiological data for the total prevalent and diagnosed prevalent cases of Celiac Disease in EU5 from 2013-2023.

Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The number of ways celiac disease can affect patients, combined with a lack of training in medical schools and primary care residency programs, contributes to the poor diagnosis rate. Currently it is estimated that 80% of the celiac disease population remains undiagnosed. Prevalence in Western Europe ranges between 1 in 133. It is higher in relatives of people with celiac disease. Women are affected more commonly than men, but there is no age predilection. DelveInsight forecasts predict that the total prevalent cases of Celiac Disease in EU5 is expected to accentuate up to 3.2 Million by 2023 at a Compound Annual Growth Rate (CAGR) of 2.21% from 2013-2023, while the diagnosed prevalent population of Celiac Disease shall grow at a CAGR of 2.86% for the forecast period (2013-2023).

There is no targeted therapy approved for celiac disease. The current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to reduce symptoms in severe cases. Owing to the expected launch of Larazotide Acetate (Innovate Pharmaceuticals) in 2021 followed by the launch of Latiglutenase (ImmunogenX/Abbvie) in 2023, shall lead to a hike in the otherwise stable, market size of celiac disease. DelveInsight estimates suggest that the EU5 market size is expected to grow at a CAGR of 49.3% from 2013-2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- It focuses on the detailed historical and forecasted number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for EU5 countries from 2013-2023.

- The Report also includes historical and forecasted Market size of Celiac Disease for EU5 countries from 2013 to 2023.

- It provides the information of available marketed therapies, including off-label biologics, patent and exclusivity details.

- The report also focuses on the details of pipeline drugs in the pivotal stage of development including their SWOT Analysis and expected launch date, which shall help to predict the impact of those drugs on the market size in the near future.

Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023- EU5

Table of Contents

Report Introduction
Celiac Disease Overview
Celiac Disease Types
Non-Responsive or Refractory CD
Etiology
Symptoms
Diagnosis
Disease Management
Disease Treatment
Treatment of Celiac Disease
Treatment of Non-Responsive or Refractory Celiac Disease (RCD)
Current Unmet Medical Needs
Epidemiology Parameters
Iceberg Model
Genetic Predisposition
Epidemiology &Patient Population
France
Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Germany
Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Italy
Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Spain
Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
United Kingdom
Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Emerging Phase III Therapies
Larazotide acetate
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
Latiglutenase
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
AMG 714
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
Celiac Disease Market Size
Italy
Total Market Size of Celiac Disease (2013-2023)
Germany
Total Market Size of Celiac Disease (2013-2023)
France
Total Market Size of Celiac Disease (2013-2023)
United Kingdom
Total Market Size of Celiac Disease (2013-2023)
Spain
Total Market Size of Celiac Disease (2013-2023)
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1:Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Table 2:Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Table 3:Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Table 4:Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Table 5:Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Table 6: Larazotide acetate, Clinical Trials by Zone, 2016
Table 7: Latiglutenase, Clinical Trials by Zone, 2016
Table 8: AMG 714, Clinical Trials by Zone, 2016
Table 9: Italy market size of Celiac Disease in USD, Million(2013-2023)
Table 10: Germany market size of Celiac Disease in USD, Million(2013-2023)
Table 11: France market size of Celiac Disease in USD, Million(2013-2023)
Table 12: United Kingdom market size of Celiac Disease in USD, Million(2013-2023)
Table 13:Spain market size of Celiac Disease in USD, Million(2013-2023)

List of Figures

Figure 1: Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Figure 2: Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Figure 3: Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Figure 4: Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Figure 5: Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Figure 6: Larazotide acetate, Clinical Trials by Zone (%), 2016
Figure 7: Latiglutenase, Clinical Trials by Zone (%), 2016
Figure 8: AMG 714, Clinical Trials by Zone (%), 2016
Figure 9: Italy market size of Celiac Disease in USD, Million(2013-2023)
Figure 10: Germany market size of Celiac Disease in USD, Million (2013-2023)
Figure 11: France market size of Celiac Disease in USD, Million(2013-2023)
Figure 12: United Kingdom market size of Celiac Disease in USD, Million(2013-2023)
Figure 13: Spain market size of Celiac Disease in USD, Million(2013-2023)
  • Global Luxury Apparels Market To Do Well Owing To Numerous International Brands
    The global luxury apparels market is fired by the intensifying number of fashion marques and many designers getting wide-ranging clienteles in the form of cost-effective products. The global luxury apparels market was at US$1, 8842.69 million in 2015 and is forecast to reach US$60,793.7 million by the end of 2024. This segment of luxury goods [...]
  • Global Health and Wellness Market Boosted By Organic Products and Wearables
    Healthcare has constantly been a profitable area where buyers spend belligerently. But now, with increasing disposable earnings amid the city population and ground-breaking approaches and innovative products being developed, the overall health and wellness market is estimated for a healthy prospect. The health and wellness market is presently very dynamic owing to growing alertness amongst [...]
  • Increasing New Outlets And Striking Offers To Drive Global Pizza Market
    The global pizza market is predicted to grow at a steady CAGR of about 3% by 2020. Pizza has been gaining massive acceptance globally in the last few years. Consequently, the global pizza market is anticipated to observer considerable progress in the coming years. The growing number of pizzerias is one of the major elements [...]
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Gastritis - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 44
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Pipeline Review, H2 2016, provides an overview of the Gastritis (Gastrointestinal) pipeline landscape.Gastritis is characterized by inflammation or swelling of the lining of the stomach. Acute gastritis lasts for a short period of time while chronic gastritis lasts for a long period of time (months to years). Gastritis can be caused by medications such as ibuprofen, aspirin, naproxen on long period......
  • Peritonitis - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 48
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Pipeline Review, H2 2016, provides an overview of the Peritonitis (Gastrointestinal) pipeline landscape.Peritonitis is inflammation of the peritoneum. There are two types of peritonitis. Spontaneous bacterial peritonitis (SBP) is the result of an infection of the fluid in peritoneal cavity. Secondary peritonitis is usually due to an infection that has spread from digestive tract. Symptoms include......
  • Irritable Bowel Syndrome - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 140
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2016, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Inflammatory Bowel Diseases (IBD) is a broad term that describes conditions with chronic or recurring immune response and inflammation of the gastrointestinal tract. Signs and symptoms include abdominal cramps and pain, diarrhea that may be bloody, weight loss, loss of......
  • Celiac Disease (CD) - Epidemiology Insights-2023- EU5
    Published: 01-Nov-2016        Price: US 1750 Onwards        Pages: 60
    DelveInsight's "Celiac Disease (CD) - Epidemiology Insights-2023- EU5" report provides an overview of the Celiac Disease and current scenario of the disease in the EU5 countries (France, Germany, Italy, Spain and UK)). It also includes historical and forecasted epidemiological data for the total prevalent and diagnosed prevalent cases of Celiac Disease in EU5 from 2013-2023. Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intesti......
  • Celiac Disease (CD) - Epidemiology Insights-2023- United States
    Published: 01-Nov-2016        Price: US 1750 Onwards        Pages: 60
    DelveInsight's "Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023-United States" report provides an overview of the Celiac Disease and current scenario of the disease in the United States. It also includes historical and forecasted epidemiological data for the diagnosed prevalent cases of Celiac Disease in the United States from 2013-2023. Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The nu......
  • Diarrhea-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Diarrhea-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Diarrhea. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, p......
  • Duodenal Ulcer-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Duodenal Ulcer-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Duodenal Ulcer. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions,......
  • Dyspepsia-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Dyspepsia-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Dyspepsia. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings,......
  • Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
    Published: 01-Nov-2016        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Acid Indigestion / Heartburn/ Pyrosis Report is to understand the market and pipeline status of the drugs around the Acid Indigestion / Heartburn/ Pyrosis to explore the generic development opportunit......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs